Hayfa Almutary1,2,3, Clint Douglas1, Ann Bonner1,3,4. 1. School of Nursing, Queensland University of Technology, Brisbane, Queensland, Australia. 2. School of Nursing, King Abdulaziz University, Jeddah, Saudi Arabia. 3. Chronic Kidney Disease Centre for Research Excellence, University of Queensland, Brisbane, Queensland, Australia. 4. Renal Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Abstract
AIMS: To explore the existence of symptom clusters in advanced chronic kidney disease. BACKGROUND: People with chronic kidney disease commonly report multiple symptoms. However, the complex relationships among these symptoms are still poorly understood. DESIGN: Cross-sectional. METHODS: A total of 436 people with stage 4 and 5 chronic kidney disease were recruited from three tertiary hospitals during 2013-2014. Participants completed the Chronic Kidney Disease-Symptom Burden Index that assesses four symptom dimensions (occurrence, distress, severity and frequency) of 32 symptoms. Exploratory factor analysis was used to identify symptom clusters across each symptom dimension. Core symptoms in each cluster were determined based on stability across dimensions and clinical plausibility. A high cutoff of 0·50 for factor loading was used for all analyses. RESULTS: Five symptom clusters were consistently identified across all symptom dimensions: fluid volume symptoms, neuromuscular symptoms, gastrointestinal symptoms, sexual symptoms and psychological symptoms. Overall, clusters ranged from 2-10 symptoms. Several symptoms were also interconnected with multiple clusters. Fatigue cross-loaded on all five clusters, whereas sleep disturbance and restless leg symptoms cross-loaded across three clusters. CONCLUSIONS: Adopting a symptom cluster approach has the potential to significantly advance symptom assessment and nursing care for people in advanced stages of chronic kidney disease. Routine clinical assessment and management strategies targeted at the cluster level should have synergistic effects in reducing symptoms. Fatigue is a pervasive symptom in advanced chronic kidney disease that is interconnected with global symptom burden, suggesting better management of symptom clusters may also reduce fatigue.
AIMS: To explore the existence of symptom clusters in advanced chronic kidney disease. BACKGROUND:People with chronic kidney disease commonly report multiple symptoms. However, the complex relationships among these symptoms are still poorly understood. DESIGN: Cross-sectional. METHODS: A total of 436 people with stage 4 and 5 chronic kidney disease were recruited from three tertiary hospitals during 2013-2014. Participants completed the Chronic Kidney Disease-Symptom Burden Index that assesses four symptom dimensions (occurrence, distress, severity and frequency) of 32 symptoms. Exploratory factor analysis was used to identify symptom clusters across each symptom dimension. Core symptoms in each cluster were determined based on stability across dimensions and clinical plausibility. A high cutoff of 0·50 for factor loading was used for all analyses. RESULTS: Five symptom clusters were consistently identified across all symptom dimensions: fluid volume symptoms, neuromuscular symptoms, gastrointestinal symptoms, sexual symptoms and psychological symptoms. Overall, clusters ranged from 2-10 symptoms. Several symptoms were also interconnected with multiple clusters. Fatigue cross-loaded on all five clusters, whereas sleep disturbance and restless leg symptoms cross-loaded across three clusters. CONCLUSIONS: Adopting a symptom cluster approach has the potential to significantly advance symptom assessment and nursing care for people in advanced stages of chronic kidney disease. Routine clinical assessment and management strategies targeted at the cluster level should have synergistic effects in reducing symptoms. Fatigue is a pervasive symptom in advanced chronic kidney disease that is interconnected with global symptom burden, suggesting better management of symptom clusters may also reduce fatigue.
Authors: Zakariya Al Naamani; Kevin Gormley; Helen Noble; Olinda Santin; Mohammed Al Maqbali Journal: BMC Nephrol Date: 2021-04-28 Impact factor: 2.388
Authors: Rebecca S Ahdoot; Kamyar Kalantar-Zadeh; James O Burton; Mark B Lockwood Journal: Curr Opin Nephrol Hypertens Date: 2022-01-01 Impact factor: 3.416
Authors: Currie Moore; Shalini Santhakumaran; Glen P Martin; Thomas J Wilkinson; Fergus J Caskey; Winnie Magadi; Rachel Gair; Alice C Smith; David Wellsted; Sabine N van der Veer Journal: PLoS One Date: 2022-03-02 Impact factor: 3.240
Authors: Se Hee Min; Qing Yang; Se Won Min; Leila Ledbetter; Sharron L Docherty; Eun-Ok Im; Sharron Rushton Journal: Womens Health (Lond) Date: 2022 Jan-Dec
Authors: A C Nixon; T J Wilkinson; H M L Young; M W Taal; N Pendleton; S Mitra; M E Brady; A P Dhaygude; A C Smith Journal: BMC Nephrol Date: 2020-09-23 Impact factor: 2.388